Pfizer delays filings on epilepsy drug to 2003
Pfizer Inc. said U.S. and European filings for its experimental epilepsy drug, pregabalin, will be delayed until next year because the company has been asked to provide more information from
Pfizer Inc. said U.S. and European filings for its experimental epilepsy drug, pregabalin, will be delayed until next year because the company has been asked to provide more information from